Robotska radikalna prostatektomija pomoću Senhance sustava
| Autor: | Kuliš, Tomislav, Hudolin, Tvrtko, Penezić, Luka, Zekulić, Toni, Saić, Hrvoje, Sambolić, Tomislav, Bačak Kocman, Iva, Goluža, Eleonora, Knežević, Nikola, Kaštelan, Željko |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Acta clinica Croatica Volume 61. Issue Supplement 3 |
| ISSN: | 1333-9451 0353-9466 |
| Popis: | Since its introduction 20 years ago, robotic radical prostatectomy has become a standard of care in the treatment of localized prostate cancer in many Centers. Until recently, they have all been performed by the only available robotic platform. Senhance is a novel robotic platform that was approved for clinical use. The term Senhance was used to systematically search PubMed and Scopus databases for relevant articles that were afterward filtered for appropriate designs and data reports. There were two reports that met all of the criteria and were included in the review. Both studies were designed as prospective case series with a total of 234 patients where the data including operative data and oncological outcomes were reported. The average operative time ranged between 180 and 195 min, with estimated blood loss between 250 and 300 mL. There was 3 Clavien - Dindo grade III, and 1 Clavien - DIndo grade IV complication reported. One of the studies compared it with laparoscopy, but no significant difference in operative time and blood loss was found. Both studies concluded that the Senhance is a feasible and safe robotic platform for radical prostatectomy. Robotom asistirana radikalna prostatektomija je, od svog uvođenja u praksu prije više od dvadeset godina, postala standardna metoda liječenja lokaliziranog raka prostate. Donedavno su sve robotom asistirane radikalne prostatektomije bile učinjene koristeći jedini dostupni robotski sustav. Senhance je novi robotski sustav koji je odobren za kliničku upotrebu. Baze podataka PubMed i Scopus su pretraživane za riječ ‘’Senhance’’, a pronađeni članci su dodatno filtrirani na one koji sadrže odgovarajući dizajn studije i dostupne podatke. Dvije studije su zadovoljile navedene kriterije. Obje studije su prospektivne studije sa ukupno 234 pacijenta te su u njima objavljeni podaci koji su uključivali podatke o operativnim ishodima. Prosječno trajanje operacije je bilo između 180 i 195 minuta, sa gubitkom krvi od 250 do 300 mL. Prijavljene su 3 komplikacije Clavien - Dindo stupnja III i 1 stupnja IV. U jednoj studiji je učinjena usporedba sa laparoskopijom, ali nije nađeno značajne razlike u operativnom vremenu i gubitku krvi između dvije metode. Obje studije su utvrdile da je Senhance sigurna i primjenjiva robotska platforma za korištenje u radikalnoj prostatektomiji. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|